Realizing the potential of FAIR data for pharmaceutical R&D
Creating and using FAIR data has the potential to transform the analyses enabling drug discovery and development. Numerous resources and services can jumpstart and streamline the implementation of the FAIR Data Principles. However, adoption in the pharmaceutical industry has been slow, partially due to challenges in establishing the infrastructure. It is also critical to recognize internal hurdles in corporate organization and culture.
Read more...